Clinical trial Recruiting at 1 site Observational

Comparing two OCT imaging systems for pediatric retina evaluation

Official title: Optimize Pediatric OCT (Optical Coherence Tomography) Imaging: a Pilot Study

Run by Duke University · NCT06139523 · Data updated 2026-11-12

This study is testing two different eye imaging systems to see which one works better for looking at the retinas of children.

Quick facts

Study typeObservational
SexAll
Enrollment30 (estimated)
SponsorDuke University
Academic / other
Locations1 site (Durham, North Carolina)
StatusRecruiting
StartedJanuary 24, 2024
Main results expectedJuly 2027
Study endsDecember 2027
Registry record updatedAugust 5, 2026
Trial IDNCT06139523 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include pediatric patients under 18 years of age who are undergoing examination at the Duke Eye Center.

Probably not a fit

Patients with significant ocular issues or those unable to consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational pilot study aims to compare a new contact optical coherence tomography (OCT) system with an investigational noncontact OCT system to evaluate their effectiveness in imaging the pediatric retina. The study will enroll 10 healthy adult volunteers and 20 pediatric patients, assessing the contact system's ability to capture larger areas of the retina while maintaining similar image quality. Imaging data will be processed and analyzed at the Duke Advanced Research in SD/SSOCT Imaging Laboratory, with a focus on ensuring safety and minimizing risks associated with the imaging procedures.

Why it matters

Potential benefit: If successful, this study could enhance the accuracy and effectiveness of retinal imaging in pediatric patients, leading to better diagnosis and management of retinal diseases.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving imaging techniques for retinal evaluation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Group 1 - Healthy adult volunteers
* Subject is able and willing to consent to study participation
* Subject is more than 18 years of age
* Healthy adult volunteers without known ocular issues other than refractive error
* Pregnancy Reasonably Excluded Guide (PREG) evaluation on women of childbearing potential
* Group 2 - Pediatric participants
* Health care provider, knowledgeable of protocol, agrees that study personnel could contact the parent/legal guardian
* Parent/legal guardian is able and willing to consent to study participation
* Pediatric patient less than 18 years of age in Duke Eye Center ophthalmology clinics or undergoing clinically-indicated examination under anesthesia at Duke Eye Center

Exclusion Criteria:

* Group 1 - Healthy adult volunteers
* Students or employees under direct supervision of the investigators
* Subjects with prior problems with pupil dilation
* Pregnant woman if receiving dilating drops
* Group 2 - Pediatric participants
* Parent/legal guardian unwilling or unable to provide consent
* Participant has a health or eye condition that preclude eye examination or retinal imaging (such as corneal opacity or cataract)

Where it's running

  • Duke University Eye Center
    Durham, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Auto-aligning handheld OCT for adult and pediatric retinal imaging

    We will test a new handheld OCT device that automatically aligns to capture retinal images in healthy adults, adult eye patients, and children.

    Recruiting Duke University · Durham, North Carolina · NCT06841575

  • OCT data collection from healthy and diseased eyes (A10900)

    This project will collect Optical Coherence Tomography (OCT) scans from adults 22 and older who have retinal disease, glaucoma, corneal conditions, or are healthy to build a reference dataset for A10900.

    Recruiting at 3 sites Optos, PLC · Anaheim, California and 3 other locations · NCT07149740

  • Using stem cells to treat retinal and optic nerve damage

    This study is testing if using stem cells from your own bone marrow can help improve vision in people with serious eye damage from conditions like age-related macular degeneration and optic nerve problems.

    Recruiting at 4 sites MD Stem Cells · Westport, Connecticut and 3 other locations · NCT03011541

  • Balance training for people with glaucoma

    A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.

    Recruiting Kanuni Sultan Suleyman Training and Research Hospital · Küçükçekmece, Istanbul · NCT07910955

  • Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma

    In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.

    Recruiting Phase 4 Indiana University · Bloomington, Indiana · NCT07847073

  • Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients

    This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.

    Recruiting Tomey Corporation · Jacksonville, Florida · NCT07804277

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.